Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BTDS 10 or 20 in Opioid-naïve Chronic Low Back Pain
NCT00490919Phase 3Completed
- Sponsor
- Purdue Pharma
- Start
- Jun 2007
- Primary completion
- Jul 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of buprenorphine in chronic low back pain (CLBP), sponsored by Purdue Pharma. Started Jun 2007; status: completed.
02
Drugs
buprenorphine
03
Conditions
chronic low back pain (CLBP)
Beyond the preview
Go deeper on NCT00490919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00490919.